WO2008045009A3 - Forme posologique pharmaceutique - Google Patents

Forme posologique pharmaceutique Download PDF

Info

Publication number
WO2008045009A3
WO2008045009A3 PCT/TR2007/000121 TR2007000121W WO2008045009A3 WO 2008045009 A3 WO2008045009 A3 WO 2008045009A3 TR 2007000121 W TR2007000121 W TR 2007000121W WO 2008045009 A3 WO2008045009 A3 WO 2008045009A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosage form
coating
pharmaceutical dosage
core tablet
active ingredient
Prior art date
Application number
PCT/TR2007/000121
Other languages
English (en)
Other versions
WO2008045009A2 (fr
Inventor
Abdullah Uslu
Original Assignee
Nobel Ilac San Ve Tic A S
Abdullah Uslu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobel Ilac San Ve Tic A S, Abdullah Uslu filed Critical Nobel Ilac San Ve Tic A S
Priority to EP07852324A priority Critical patent/EP2086517A2/fr
Publication of WO2008045009A2 publication Critical patent/WO2008045009A2/fr
Publication of WO2008045009A3 publication Critical patent/WO2008045009A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

La présente invention comprenant un ingrédient actif pantoprazole consiste en un comprimé de cœur de forme posologique solide pharmaceutique, un enrobage entérique et un pré-enrobage entre le comprimé de cœur et l'enrobage entérique. Le comprimé de cœur contient l'ingrédient actif pantoprazole conjointement avec de la carboxyméthylcellulose sodique en tant que liant et de l'isomalt en tant que charge.
PCT/TR2007/000121 2006-10-10 2007-10-10 Forme posologique pharmaceutique WO2008045009A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07852324A EP2086517A2 (fr) 2006-10-10 2007-10-10 Forme posologique pharmaceutique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2006/05624 2006-10-10
TR2006/05624A TR200605624A2 (tr) 2006-10-10 2006-10-10 Farmasötik dozaj şekli

Publications (2)

Publication Number Publication Date
WO2008045009A2 WO2008045009A2 (fr) 2008-04-17
WO2008045009A3 true WO2008045009A3 (fr) 2008-12-31

Family

ID=39283297

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2007/000121 WO2008045009A2 (fr) 2006-10-10 2007-10-10 Forme posologique pharmaceutique

Country Status (3)

Country Link
EP (1) EP2086517A2 (fr)
TR (1) TR200605624A2 (fr)
WO (1) WO2008045009A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105380919A (zh) * 2015-11-20 2016-03-09 世贸天阶制药（江苏）有限责任公司 一种泮托拉唑钠肠溶片及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996001624A1 (fr) * 1994-07-08 1996-01-25 Astra Aktiebolag Preparation pharmaceutique composite renfermant un inhibiteur de pompe a protons
DE19752843A1 (de) * 1997-11-28 1999-07-01 Byk Gulden Lomberg Chem Fab Arzneimittelzubereitung in Tabletten- oder Pelletform für Pantoprazol und Omeprazol
EP1257256A1 (fr) * 2000-02-17 2002-11-20 Alpharma APS Procede de production de pellets vecteurs de medicaments

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996001624A1 (fr) * 1994-07-08 1996-01-25 Astra Aktiebolag Preparation pharmaceutique composite renfermant un inhibiteur de pompe a protons
DE19752843A1 (de) * 1997-11-28 1999-07-01 Byk Gulden Lomberg Chem Fab Arzneimittelzubereitung in Tabletten- oder Pelletform für Pantoprazol und Omeprazol
EP1257256A1 (fr) * 2000-02-17 2002-11-20 Alpharma APS Procede de production de pellets vecteurs de medicaments

Also Published As

Publication number Publication date
EP2086517A2 (fr) 2009-08-12
WO2008045009A2 (fr) 2008-04-17
TR200605624A2 (tr) 2008-05-21

Similar Documents

Publication Publication Date Title
WO2012085657A3 (fr) Formes pharmaceutiques solides à usage oral résistant à la contrefaçon
WO2009117130A3 (fr) Formulation à libération prolongée contenant une cire
EP2081550A4 (fr) Revêtement de capsules avec des ingrédients pharmaceutiques actifs
IL194290A (en) A complicated rna unit containing a two-strand region, a medicinal product containing it, a method of preparation and use thereof
WO2006011159A3 (fr) Composition pharmaceutique stabilisee contenant du sodium de rabeprazole presentant une biodisponibilite amelioree
EP1971655A4 (fr) Émulsion aqueuse durcissable aux uv, procédé pour la préparer et composition de revêtement sans solvant comprenant cette émulsion
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
IL233677A (en) Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition
PT2040755E (pt) Combinação de um inibidor de colinesterase e um composto com afinidade para o receptor 5-ht6
IL198289A (en) Processed dihydropyrazolones, processes for their preparation, medicinal preparations containing them and their use in the preparation of medicinal preparations
WO2010017821A8 (fr) Comprimés enrobés avec une surface de dégradation résiduelle dans le temps
WO2009059701A3 (fr) Comprimés à libération prolongée contenant de l'hydromorphone
WO2008129517A3 (fr) Composition pharmaceutique à libération prolongée stabilisée de rabéprazole
IL196697A (en) Use of 4 Hydroxy-Alpha-Phenyl Butyl Nitron or its Derivatives to Prepare a Cure for Sensory-Neural Hearing Loss
WO2012022919A3 (fr) Formulations à base de nalbuphine et leurs utilisations
WO2011005052A3 (fr) Nouveaux dérivés imidazole-4-carboxamide contenant de l'arylpipérazine et composition pharmaceutique contenant ces dérivés
WO2009019477A3 (fr) Revêtement
WO2011140446A3 (fr) Formulations pharmaceutiques
BRPI0720314A2 (pt) Composição, e, usos de uma composição e de um composto de triazol.
WO2011107944A3 (fr) Forme pharmaceutique à libération modifiée
WO2009135951A3 (fr) Procédé pour préparer un comprimé contenant de la metformine
WO2010018175A3 (fr) Formulation pharmaceutique orale pour l’oméprazole comprenant une couche de séparation spécifique
WO2008045009A3 (fr) Forme posologique pharmaceutique
WO2009006299A3 (fr) Systèmes à multiples particules
WO2009133455A3 (fr) Composition pharmaceutique de clopidogrel

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007852324

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07852324

Country of ref document: EP

Kind code of ref document: A2